Finance

Beta
Lists
215600:KOSDAQ
SillaJen Inc
â‚©2,320.00
+0.87%
(+20.00) 1D
Jul 1, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 215600...
Open
â‚©2,315
High
â‚©2,445
Low
â‚©2,255
Mkt. cap
321.44B
Avg. vol.
707.43K
Volume
448.67K
52-wk high
â‚©5,400
52-wk low
â‚©2,185
EPS
-â‚©175
Shares outstanding
138.55M
No. of employees
57
Open
â‚©2,315
High
â‚©2,445
Low
â‚©2,255
Mkt. cap
321.44B
Avg. vol.
707.43K
Volume
448.67K
52-wk high
â‚©5,400
52-wk low
â‚©2,185
EPS
-â‚©175
Shares outstanding
138.55M
No. of employees
57
News stories
From sources across the web
Profile
SillaJen, Inc. is a South Korean-based biotechnology company, with offices in Busan, Yangsan and Seoul, South Korea, and San Francisco, California. Wikipedia
About SillaJen Inc
CEO-
Employees57
Founded2003
Headquarters-
SectorBiotechnology
Websitesillajen.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.39B
2.76B
2.91B
2.85B
Cost of goods sold
13.53B
8.90B
-19.81B
-
Cost of revenue
13.53B
8.90B
-19.81B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-4.77B
-
30.01B
8.25B
Operating expense
-4.95B
-
30.86B
8.50B
Total operating expenses
8.58B
8.90B
11.06B
8.50B
Operating income
-6.19B
-6.14B
-8.15B
-5.65B
Other non operating income
133.47M
-58.46M
-150.50M
17.71M
EBT including unusual items
-5.58B
-5.48B
-7.84B
-4.91B
EBT excluding unusual items
-5.95B
-5.48B
-7.29B
-4.95B
Income tax expense
-75.98M
391.89M
-3.98M
-
Effective tax rate
1.36%
-7.14%
0.05%
-
Other operating expenses
-
-
-
-
Net income
-5.51B
-5.88B
-7.84B
-4.91B
Net profit margin
-230.23%
-212.58%
-269.13%
-172.19%
Earnings per share
-
-
-
-
Interest and investment income
781.06M
898.14M
1.10B
817.16M
Interest expense
-680.88M
-188.68M
-
-94.57M
Net interest expenses
100.18M
709.47M
1.10B
722.60M
Depreciation and amortization charges
-179.92M
-
866.24M
231.46M
EBITDA
-5.96B
-5.92B
-7.92B
-5.42B
Gain or loss from assets sale
547.57K
-2.00
29.99K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer